Concepedia
Statistics
Publications
7
Citations
761
H-Index
Active since
1991
Affiliations
Vertex Pharmaceuticals (United States)(Current)
Saarland University
Amsterdam UMC Location University of Amsterdam
University of Amsterdam
Susan Purdy is an author at Vertex Pharmaceuticals (United States) specializing in antiviral therapy, viral hepatitis, and pharmacy.
Publications per year
1991–2008
Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study
Hendrik W. Reesink, Stefan Zeuzem, Christine J. Weegink et al. · Gastroenterology · 2006 · 396 citations
Pharmacy, Infectious Diseases, Pharmacotherapy +13
Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C
Nicole Forestier, Hendrik W. Reesink, Christine J. Weegink et al. · Hepatology · 2007 · 253 citations
Pharmacy, Infectious Diseases, Pharmacotherapy +16
Stimulation of steroidogenesis by forskolin in rat adrenal zona glomerulosa cell preparations
Susan Purdy, B. J. Whitehouse, D.R.E. Abayasekara · Journal of Endocrinology · 1991 · 31 citations
Life Sciences, Endocrinology, Physiology +17
Phase 2 study of the combination of merimepodib with peginterferon-α2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C
Patrick Marcellin, Yves Horsmans, Frederik Nevens et al. · Journal of Hepatology · 2007 · 29 citations
Pharmacy, Pharmacology, Pharmacotherapy +16
737 Initial results of a 14-day study of the hepatitis C virus inhibitor protease VX-950, in combination with peginterferon-alpha-2a
H.W. Reesink, N. Forestiere, Christine J. Weegink et al. · Journal of Hepatology · 2006 · 25 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +12
1–5 of 7